lysosomal酸脂酶缺乏谱从婴儿期到成年期:一个多学科的经验
Raffaele Buganza1, Riccardo Faletti2, Maria Donata Di Taranto3
1Department of Public Health and Pediatric Sciences, Ospedale Infantile Regina Margherita, University of Turin, Italy.
Nutrition, metabolism, and cardiovascular diseases : NMCD
|September 12, 2025
概括
溶解体酸脂酶缺乏症 (LAL-D) 的诊断是具有挑战性的. 降脂疗法 (LLT) 有效治疗胆固醇乙储存疾病 (CESD),而酶替代疗法 (ERT) 对沃尔曼至关重要.
科学领域:
- 遗传学和罕见疾病.
- 代谢障碍 代谢障碍 代谢障碍
- 肝病学 肝病学是一种肝病学.
背景情况:
- lysosomal acid lipase (LAL) 缺乏症 (LAL-D) 是一种极为罕见的自体递归性疾病.
- 它呈现为严重的沃尔曼病 (WD) 或较轻的胆固醇乙储存疾病 (CESD).
- 诊断延迟和治疗有效性是严重的问题.
研究的目的:
- 解决LAL-D的诊断和治疗挑战.
- 在CESD患者中探索降脂疗法 (LLT) 的长期影响.
主要方法:
- 30年来对7名LAL-D患者 (2名WD婴儿,5名CESD儿童/成年人) 的回顾性分析.
- 包括生物化学分析,LAL酶活性,LIPA基因变异和肝脏评估.
- 通过成像和活检评估动脉内膜厚度和肝脏状况.
主要成果:
- 由于表现变化,CESD诊断延迟 (4-52年).
- 在9个月之前,WD婴儿出现了严重的症状和死亡率.
- 在4/5的CESD患者中,以泽提治疗改善了LDL-C (19%) 和ALT (21.6%),而没有纤维化进展.
结论:
- LAL-D模仿其他脂质和肝脏疾病,需要准确的诊断.
- 建议LLT作为CESD的第一线治疗.
- ERT是WD的主要治疗方法,也是不响应CESD的次要选择.
相关概念视频
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Chronic Pancreatitis II: Collaborative Care
317
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
317
Lipid Digestion
98.8K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
98.8K
Overview of Lipid Metabolism
4.9K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.9K
Inborn Errors of Metabolism
699
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
699
Lipid Absorption
2.5K
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
2.5K


